Introducing Women's Regenerative Therapies & iPSC Cell Banking in Japan
Discover advanced regenerative medicine leveraging Japan's leadership in autologous Mesenchymal Stem Cell and iPSC (induced pluripotent stem cell) technology, guided by stringent PMDA regulatory oversight. The program focus on education on personalized medicine - cellular repair, metabolic and immune resilience, specialized women's regenerative and menopause support. Learn ways to help you maintain vitality and a robust healthspan.
Why Japan ā World Leader in Regenerative Medicine Regulation
Japan stands at the forefront of regenerative medicine, offering a unique blend of world-class innovation and stringent regulatory oversight. This commitment to both safety and pioneering therapies makes it an unparalleled global leader.
World-Class Safety & Innovation Framework
Japan's pioneering Act on the Safety of Regenerative Medicine and the Pharmaceuticals and Medical Devices Act (PMDA) enforce strict review and regulation of stem cell therapies, guaranteeing both innovation and patient safety.
Trusted National Oversight
Oversight by Ministry of Health, Labour and Welfare of Japan and PMDA, Japan's national agencies, ensures rigorous yet efficient review systems, enabling early clinical access under ethically sound frameworks.
Global Benchmark for Regenerative Therapy
Japan led the way in 2014 with dedicated Regenerative Medicine Law, continuously refining them to create clear, accelerated pathways for advanced cell and gene therapies.
Our IUVENTUS Commitment
IUVENTUS partners exclusively with certified Japanese clinics and cGMP facilities, operating under these stringent laws, ensuring unparalleled patient safety, scientific credibility, and transparent compliance.
** Regulatory Compliance
All referred programs operate under Japanās Act on the Safety of Regenerative Medicine (ASRM) and the Pharmaceuticals and Medical Devices Act (PMD Act).
Each program is reviewed by certified ethics committees and supervised by the Ministry of Health, Labour and Welfare (MHLW) and the Pharmaceuticals and Medical Devices Agency (PMDA).
Reframe Aging. Restore Vitality. Renew Your Healthspan.
š Discovery Consultation
Begin your journey with an in-depth assessment. Ideal for understanding your cellular health profile and exploring personalized regenerative strategies.
ā Core Revitalization Protocols
Designed for focused cellular repair and maintaining vitality. These programs leverage Japanās advanced iPSC technology under PMDA regulatory guidance..
š Comprehensive Healthspan Programs
Our most advanced programs for holistic well-being, integrating MSC and iPSC technology with screening QC diagnostics and supportive therapies to optimize cellular repair capacity, emotional/cognitive stability, and metabolic/immune resilience.
Leading Research Facilities
Access Japan's most advanced Women's Health and iPSC regenerative medicine facilities, renowned for their innovation and clinical excellence in Tokyo's Central districts.
Cutting-Edge en-MSC & iPSC Technology
Harnessing state-of-the-art en-MSC and iPSC cultivation labs and internationally compliant stem cell - related programs and protocols, all under the strict oversight of Japan's PMDA regulatory body.
Accredited and Specialized Clinical Teams
Benefit from board-certified specialists in iPSC cell banking, regenerative medicine, and dedicated women's regenerative health & menopause support, ensuring expert guidance for your unique needs.
Comprehensive Client Journey
Our end-to-end medical excellence program provide full support, including translation and concierge. Contact us at [email protected] or WhatsApp: +65 8816 8470 for a consultative approach to your vitality.
*Disclaimer: i. IUVENTUS provides information and referral services only. We do not diagnose, prescribe, or perform any medical procedures. ii. Clients are advised to consult their local healthcare provider before considering any regenerative procedures abroad. IUVENTUS supports informed decision-making with full awareness of potential risks and benefits. iii. All treatments are conducted by licensed Japanese clinics under PMDA oversight. Results and outcomes vary depending on each individualās health and condition.